Status | Study |
Enrolling by invitation |
Study Name: TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors Condition: Ovarian Sex Cord Stromal Tumor Ovarian Neoplasms Date: 2015-04-24 Interventions: Drug: Paclitaxel Patients rece |
Active, not recruiting |
Study Name: Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR) Condition: Ovarian Sex-cord Stromal Tumor Date: 2013-01-15 Interventions: Drug: Paclitaxel Drug: Bevacizumab |
Recruiting |
Study Name: Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Condition: Ovarian Granulosa Cell Tumor Ovarian Gynandroblastoma Ovar Date: 2010-01-01 Interventions: Biological: Bleomycin Sulfate |
Active, not recruiting |
Study Name: Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary Condition: Malignant Ovarian Epithelial Tumor Ovarian Granulosa Cell Tumor Date: 2008-09-05 Interventions: Biological: Bevacizumab Given |
Completed |
Study Name: Paclitaxel in Treating Patients With Ovarian Stromal Cancer Condition: Adult Type Ovarian Granulosa Cell Tumor Ovarian Gynandroblastoma Date: 2000-09-11 Interventions: Drug: Paclitaxel Given IV Other Names: |